MFS
CAPR icon

MSI Financial Services’s Capricor Therapeutics CAPR Stock Holding History

MSI Financial Services’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$0 Hold
1
– – ﹤0.01% 3833
2016
Q3 		$0 Hold
1
– – ﹤0.01% 3876
2016
Q2 		$0 Hold
1
– – ﹤0.01% 3926
2016
Q1 		$0 Hold
1
– – ﹤0.01% 3957
2015
Q4 		$0 Buy
+1
New +$40 ﹤0.01% 3854

Other funds holding CAPR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

MSI Financial Services's CAPR Position: Q4 2016 in Review

MSI Financial Services held its Capricor Therapeutics (CAPR) position steady in Q4 2016 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3833.

MSI Financial Services first reported a position in CAPR in Q4 2015 and has held it in 5 quarters since. 20 funds tracked by Wall St. Rank hold CAPR as of Q4 2016.

  • MSI Financial Services held 1 share of Capricor Therapeutics worth $0 as of Q4 2016.
  • MSI Financial Services left its Capricor Therapeutics share count unchanged in Q4 2016.
  • Capricor Therapeutics made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3833 holding.
  • MSI Financial Services first reported a position in Capricor Therapeutics in Q4 2015 and has held it in 5 quarters since.
  • 20 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.